For the Inventor, By the Inventor

Enter assignee name

St. Louis, MO, United States of America

Curium US LLC

USPTO Granted Patents = 47

% Expired Patents = 4.3

CIPO Patents = 2

EPO Patents = 20

Trademarks = 8

Forward Citations = 26

Loading Chart...

Loading Chart...

52 inventors (with patents filed for the assignee):

Brian Regna (16 out of 16 patents)

Lauren Radford (15 out of 15 patents)

Craig Brunkhorst (15 out of 15 patents)

4. Bryan Scott Petrofsky (11 out of 18 patents)

5. William Claude Uhland (11 out of 14 patents)

6. David Wayne Pipes (10 out of 11 patents)

7. Shaun Loveless (9 out of 9 patents)

8. Kevin Bartlett Graves (8 out of 16 patents)

9. Allan Casciola (8 out of 8 patents)

10. David Pipes (8 out of 8 patents)

11. William Uhland (8 out of 8 patents)

12. Sumit Verma (7 out of 13 patents)

13. Luis Antonio M M Barbosa (5 out of 5 patents)

14. Jarno Jalomäki (4 out of 4 patents)

15. Salla Seppänen (4 out of 4 patents)

Core Competencies:

Copper-64

Radiopharmaceutical

Actinium

Germanium-68

Xenon-133

Molybdenum-99

Gamma-ray Shield

Sterility Testing

Electroplating Sources

Chromatographic Separation

Radioactive Drug Product

Radionuclide Therapy

47 patents: Sort by Forward Citations

1. 12763228 - Copper-64 compositions and formulations (2026-10-13),

2. 12759739 - Systems and methods for producing a radioactive drug product using a dispensing unit (2026-10-13),

3. 12752026 - Radiopharmaceutical compositions for actinium in targeted radionuclide therapy (2026-10-06),

4. 12749589 - Purification process for the preparation of non-carrier added copper-64 (2026-09-29),

5. 12735327 - Copper-64 compositions and purification processes for the preparation of novel copper-64 compositions (2026-09-15),

6. 12731702 - Purification process for the preparation of non-carrier added copper-64 (2026-09-08),

7. 12721912 - Radiopharmaceutical compositions for actinium in targeted radionuclide therapy (2026-09-01),

8. 12718963 - Copper-64 compositions and formulations (2026-08-25),

9. 12603190 - Purification process for the preparation of non-carrier added copper-64 (2026-04-14),

10. 12502441 - Radiopharmaceutical compositions for low toxicity actinium in targeted radionuclide therapy (2025-12-23),

11. 12462943 - Purification process for the preparation of non-carrier added copper-64 (2025-11-04),

12. 12428177 - Systems and methods for producing a radioactive drug product using a dispensing unit (2025-09-30),

13. 12324846 - [LU] lutetium-PSMA IandT composition and dosimetry, kit, method of making, and method of using thereof (2025-06-10),

14. 12315649 - Purification process for the preparation of non-carrier added copper-64 (2025-05-27),

15. 12291448 - Systems and methods for production of Xenon-133 (2025-05-06),

Company Overview

Curium US LLC is a prominent player in the field of nuclear medicine, specializing in the development and manufacturing of radiopharmaceuticals. The company focuses on innovative solutions for diagnostic imaging and targeted therapies, contributing significantly to the advancement of patient care in oncology and other medical disciplines. Headquartered in St. Louis, Missouri, Curium leverages its expertise to enhance the efficacy of medical treatments and improve patient outcomes through cutting-edge technology and research.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

47 Patents

#54 in St. Louis, MO

#90 in Missouri

#7,437 in US

#14,821 in the World

St. Louis, MO, United States of America

Curium US LLC

Forward Citations = 26

52 inventors:

Brian Regna (16 out of 16 patents)

Lauren Radford (15 out of 15 patents)

Craig Brunkhorst (15 out of 15 patents)

4. Bryan Scott Petrofsky (11 out of 18 patents)

5. William Claude Uhland (11 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Curium US LLC. Retrieved from https://idiyas.com/company/curium-us

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…